Measuring the risks and rewards of drug development: New research from MIT shows that the success rates of clinical trials are higher than previously thought
By
The study has broad implications for investors, regulators, policymakers, and clinicians
By
The study has broad implications for investors, regulators, policymakers, and clinicians
By
Are you experimenting with artificial intelligence, or are you “AI future-ready”? A new model maps four stages of enterprise AI maturity.
By
You don’t have to be a therapist to help someone reexamine their career. But it does require leading by example and hard conversations.
By
American focus on assertiveness may hold East Asians back from corporate leadership.
By
While the Russia-Ukraine war is taking a devastating toll on land, a second war is unfolding on the internet.
By
Ami Danoff talks punctuality, working with competing personalities, and the importance of making “pit stops” in a career.
By
A new research brief from MIT examines what digital innovation means for workers, training, and strategy at U.S. firms.
By
The COVID-19 Policy Alliance put online a set of data analytic tools to enable states to identify the highest risk facilities and localities.
By
MIT Sloan special report offers leaders a strategic approach to using AI to solve critical business problems.
By
When banks tighten lending standards following a shock, they can set off a chain reaction that can worsen and prolong a credit crunch.